Literature DB >> 21178960

Expression, detergent solubilization, and purification of a membrane transporter, the MexB multidrug resistance protein.

Forum H Bhatt1, Constance J Jeffery.   

Abstract

Multidrug resistance (MDR), the ability of a cancer cell or pathogen to be resistant to a wide range of structurally and functionally unrelated anti-cancer drugs or antibiotics, is a current serious problem in public health. This multidrug resistance is largely due to energy-dependent drug efflux pumps. The pumps expel anti-cancer drugs or antibiotics into the external medium, lowering their intracellular concentration below a toxic threshold. We are studying multidrug resistance in Pseudomonas aeruginosa, an opportunistic bacterial pathogen that causes infections in patients with many types of injuries or illness, for example, burns or cystic fibrosis, and also in immuno-compromised cancer, dialysis, and transplantation patients. The major MDR efflux pumps in P. aeruginosa are tripartite complexes comprised of an inner membrane proton-drug antiporter (RND), an outer membrane channel (OMF), and a periplasmic linker protein (MFP). The RND and OMF proteins are transmembrane proteins. Transmembrane proteins make up more than 30% of all proteins and are 65% of current drug targets. The hydrophobic transmembrane domains make the proteins insoluble in aqueous buffer. Before a transmembrane protein can be purified, it is necessary to find buffer conditions containing a mild detergent that enable the protein to be solubilized as a protein detergent complex (PDC). In this example, we use an RND protein, the P. aeruginosa MexB transmembrane transporter, to demonstrate how to express a recombinant form of a transmembrane protein, solubilize it using detergents, and then purify the protein detergent complexes. This general method can be applied to the expression, purification, and solubilization of many other recombinantly expressed membrane proteins. The protein detergent complexes can later be used for biochemical or biophysical characterization including X-ray crystal structure determination or crosslinking studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178960      PMCID: PMC3159675          DOI: 10.3791/2134

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

Review 1.  Surfactants in membrane solubilisation.

Authors:  M N Jones
Journal:  Int J Pharm       Date:  1999-01-25       Impact factor: 5.875

Review 2.  Interaction of membrane proteins and lipids with solubilizing detergents.

Authors:  M le Maire; P Champeil; J V Moller
Journal:  Biochim Biophys Acta       Date:  2000-11-23

3.  An elegant means of self-protection in gram-negative bacteria by recognizing and extruding xenobiotics from the periplasmic space.

Authors:  Shima Eda; Hideaki Maseda; Taiji Nakae
Journal:  J Biol Chem       Date:  2002-12-01       Impact factor: 5.157

4.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex.

Authors:  Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

5.  The role of protein and surfactant interactions in membrane-protein crystallization.

Authors:  Bryan W Berger; Colleen M Gendron; Clifford R Robinson; Eric W Kaler; Abraham M Lenhoff
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-05-26

6.  AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.

Authors:  H Okusu; D Ma; H Nikaido
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

7.  The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa.

Authors:  H Yoneyama; A Ocaktan; M Tsuda; T Nakae
Journal:  Biochem Biophys Res Commun       Date:  1997-04-28       Impact factor: 3.575

8.  Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

9.  Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.

Authors:  X Z Li; H Nikaido; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.

Authors:  X Z Li; D Ma; D M Livermore; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

View more
  2 in total

1.  Expression of Recombinant Insulin-Like Growth Factor-Binding Protein-3 Receptor in Mammalian Cell Line and Prokaryotic (Escherichia coli) Expression Systems.

Authors:  Nima Naseri; Mina Mirian; Mohammad Reza Mofid
Journal:  Adv Biomed Res       Date:  2022-02-28

2.  Resistance index of penicillin-resistant bacteria to various physicochemical agents.

Authors:  M Kazemi; R Kasra Kermanshahi; E Heshmat Dehkordi; F Payami; M Behjati
Journal:  ISRN Microbiol       Date:  2012-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.